AVID BIOSERVICES INC's ticker is CDMO and the CUSIP is 05368M106. A total of 2 filers reported holding AVID BIOSERVICES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120 | -32.6% | 12,715 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $178 | -25.5% | 12,715 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $239 | +36.6% | 12,715 | -0.2% | 0.01% | +33.3% |
| Q4 2022 | $175 | -99.9% | 12,744 | 0.0% | 0.01% | -45.5% |
| Q3 2022 | $244,000 | +25.8% | 12,744 | 0.0% | 0.01% | +10.0% |
| Q2 2022 | $194,000 | -25.4% | 12,744 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $260,000 | -30.1% | 12,744 | 0.0% | 0.01% | -29.4% |
| Q4 2021 | $372,000 | +35.3% | 12,744 | 0.0% | 0.02% | +30.8% |
| Q3 2021 | $275,000 | -15.6% | 12,744 | +0.2% | 0.01% | -13.3% |
| Q2 2021 | $326,000 | +40.5% | 12,715 | 0.0% | 0.02% | +36.4% |
| Q1 2021 | $232,000 | +57.8% | 12,715 | 0.0% | 0.01% | +37.5% |
| Q4 2020 | $147,000 | +51.5% | 12,715 | 0.0% | 0.01% | +33.3% |
| Q3 2020 | $97,000 | +16.9% | 12,715 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $83,000 | – | 12,715 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 2,346,961 | $42,785,000 | 20.16% |
| AltraVue Capital, LLC | 2,340,200 | $42,661,000 | 9.44% |
| Sargent Investment Group, LLC | 877,382 | $15,995,000 | 4.21% |
| Parkman Healthcare Partners LLC | 675,000 | $12,305,000 | 2.86% |
| AWM Investment Company, Inc. | 1,233,000 | $22,478,000 | 2.51% |
| Ranger Investment Management | 2,003,863 | $36,530,000 | 2.01% |
| Legato Capital Management LLC | 352,844 | $6,432,000 | 1.21% |
| SNYDER CAPITAL MANAGEMENT L P | 2,189,968 | $39,923,000 | 1.15% |
| Pier Capital, LLC | 593,937 | $10,827,000 | 1.03% |
| EAM Global Investors LLC | 186,109 | $3,393,000 | 0.94% |